Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
04 June 2014 08:43
Scientists say one in four smokers with the defective gene BRCA2 will develop lung cancer
New research has discovered that a quarter of smokers with the defective gene BRCA2 will suffer from lung cancer during their lives.
The mutated gene, which is found in 2% of humans, has been associated with ovarian cancer and breast cancer for some time but now scientists say those who have it are nearly twice as likely as other people to have cancer of the lungs.
Around 13% of the 10 million Brits who smoke develop the disease during their lives but the risk is 25% among those with the gene flaw, as many as 200,000 people.
The leader of the research, Professor Richard Houlston, said that for smokers with the defective gene the risks of lung cancer are huge. The academic from the Institute of Cancer Research in London said the disease kills more people in Britain than any other cancer and as many as a million people around the world every year. The best way to prevent it is not smoking but it is even more crucial for people with the BRCA2 flaw, he said.
The study of 17,000 people across Europe, some with lung cancer and some without, looked for key differences and discovered a clear link between the disease and those participants with the c.9976T alteration to the BRCA2 gene. The connection was even more evident in those suffering from the most common type of the disease, known as squamous cell lung cancer. The scientists also found a connection between squamous cell lung cancer and another gene called CHEK2. Those suffering from the disease can arrange cancer travel insurance to protect them while on holiday.
Professor Houlston and his team think the findings from the study, which have been revealed in the Nature Genetics journal, could change the way people with the BRCA2 gene and lung cancer are treated in the future.
Doctors treating cancer patients with the BRCA2 gene who have developed breast or ovarian cancer have had some success by giving them drugs known as PARP inhibitors, but it is not yet known how they affect lung cancer, which is usually a fatal condition.
22 June 2018
The number of older people diagnosed with cancer is set to increase dramatically over the next 20 years, according to experts.
[more...]
21 June 2018
Patients value their relationship with a GP more importantly than surgery opening times, according to new research.
Only 3% of patients with the most common type of pancreatic cancer are living more than five years after being diagnosed, new analysis has shown.
19 June 2018
An England fan has urged supporters back home to head to Russia and experience the warm welcome he's been enjoying from locals.
14 June 2018
A new, low-cost portable device to help protect communities in Columbia from contaminated water has been developed by British engineers.
12 June 2018
As we near the opening match of football's grandest celebration on Thursday, fans are beginning to arrive in enthusiastic droves in Moscow.
09 June 2018
Scientists are trialling blood tests to find out the risk expecting mothers have of delivering prematurely.
08 June 2018
The Foreign and Commonwealth Office (FCO) has warned holiday-goers that some commonly-prescribed medicines are "controlled drugs" in certain countries.
A new lung cancer drug which is said to stretch life expectancy by a year is being introduced to the NHS.
06 June 2018
As pollen counts hit their highest level this week, hay fever sufferers are likely to suffer.
05 June 2018
Care home demanded to make improvements amid "serious concerns"
30 May 2018
Academics have announced their plans to examine suicide risk in men, as well as the ways to reduce it.